Zobrazeno 1 - 10
of 43
pro vyhledávání: '"David R. Vandersteen"'
Publikováno v:
Journal of pediatric urology. 17(1)
Pediatric sacral neuromodulation (SNM) device duration before revision or removal is not well known. Furthermore, secondary surgeries serve as surrogates for key outcomes including complications and symptom improvement.We sought to study the rate and
Autor:
David R. Vandersteen
Publikováno v:
Journal of Pediatric Urology. 17:75
Publikováno v:
Journal of Pediatric Urology. 15:645.e1-645.e9
This study demonstrates significantly improved bowel symptoms and satisfaction with Peristeen® use in pediatric patients with neurogenic bowel. The longer patients used Peristeen®, the greater the reduction in severity of their Neurogenic bowel and
Publikováno v:
Urology. 84:911-918
Objective To evaluate our initial experience using sacral neuromodulation via implanted pulse generator as a treatment for children with dysfunctional elimination syndrome and symptoms refractory to maximum medical therapy. Materials and Methods Ther
Autor:
David R. Vandersteen, Joel C. Hutcheson, Jonathan C. Routh, Richard A. Ashley, Shawn M. McGee, Candace F. Granberg, Stephen A. Kramer, Yuri Reinberg, Janelle Fox
Publikováno v:
Journal of Pediatric Urology. 7:632-635
Objective We report the largest known series of vesicoureteral reflux (VUR) in children with urachal anomalies (UA). Methods Two institutions’ records were reviewed for children with UA (1951‒2007). Results Of 30 girls and 36 boys with UA (34 ura
Publikováno v:
Journal of Urology. 184:1615-1619
Prognostic information is limited on children with congenital anterior urethral valves or a diverticulum. We reviewed the literature and examined our clinical database to identify clinical features predicting a poor renal outcome, defined as azotemia
Autor:
David R. Vandersteen, Yuri Reinberg, Timothy J. Roth, Jonathan C. Routh, Candace F. Granberg, Pam Hollatz, Shawn M. McGee
Publikováno v:
Urology. 73:641-644
Objectives To detail a percutaneous technique of sacral nerve neuromodulation (SN) that eliminates the first-stage incisions and the need for second-stage fluoroscopy. Our group has previously described the results of SN in children with medically re
Publikováno v:
Journal of Urology. 180:306-311
Recent advances in neuromodulation have demonstrated promise in treating children with the dysfunctional elimination syndrome refractory to medical management. Sacral nerve stimulation with the InterStim implantable device has been used in adults for
Autor:
Jonathan C. Routh, Brant A. Inman, David R. Vandersteen, Douglas A. Husmann, Richard A. Ashley, James J. Wolpert, Stephen A. Kramer, Yuri Reinberg
Publikováno v:
Urology. 71:435-438
Objectives Previous studies have shown that the cure rates after dextranomer/hyaluronic acid (Dx/HA) injection can be decreased in patients with neurogenic bladder, previous ureteroneocystostomy, duplicated ureters, or periureteral diverticula. We at
Autor:
Brant A. Inman, David R. Vandersteen, Richard A. Ashley, Yuri Reinberg, Jonathan C. Routh, Douglas A. Husmann, Stephen A. Kramer, James J. Wolpert
Publikováno v:
Journal of Urology. 178:1702-1706
Numerous factors have been postulated to increase success rates for dextranomer/hyaluronic acid injection for vesicoureteral reflux. Ureteral hydrodistention combined with intraureteral injection reportedly improves injection success rates. We combin